Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Min Kim

Showing results (231-240 of 588) with videos related to

Pageof 59
Sort By:
Stem Cells (Dayton, Ohio)|May 4, 2012
Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activityXiuli Jiang, Hongyan Xing, Tae-Min Kim, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibodyKoung Jin Suh, Se Hyun Kim, Yu Jung Kim, et al.
International Journal of Cancer|June 26, 2023
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancerSeyoung Seo, Bhumsuk Keam, Seong Hoon Shin, et al.
Cancer Research and Treatment|July 2, 2026
Clinico-Pathologic Features of Adult Erdheim-Chester Disease in South Korea: A Multicenter Retrospective Study (KCSG LY22-15)Ji Yun Lee, Heounjeong Go, Myung-Won Lee, et al.
Journal of Audiology & Otology|April 19, 2017
Analysis of Effect of Eggshell Membrane Patching for Moderate-to-Large Traumatic Tympanic Membrane PerforationJong Yoon Jung, Hee-Chul Yun, Tae-Min Kim, et al.
Cancer Medicine|October 5, 2020
Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high-risk human papillomavirus cervical carcinomasJing Jing Liu, Jung Yoon Ho, Jung Eum Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristicsDohee Kwon, Jaemoon Koh, Sehui Kim, et al.
Targeted Oncology|June 8, 2017
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced CancerMichael Michael, Yung-Jue Bang, Young Suk Park, et al.
ESMO Open|August 11, 2018
Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicityShin Hye Yoo, Bhumsuk Keam, Miso Kim, et al.
Investigational New Drugs|September 17, 2013
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamideChanghoon Yoo, Jeeyun Lee, Sun Young Rha, et al.
Pageof 59

Showing results (231-240 of 588) with videos related to

Sort By:
Pageof 59
Stem Cells (Dayton, Ohio)|May 4, 2012
Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activityXiuli Jiang, Hongyan Xing, Tae-Min Kim, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibodyKoung Jin Suh, Se Hyun Kim, Yu Jung Kim, et al.
International Journal of Cancer|June 26, 2023
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancerSeyoung Seo, Bhumsuk Keam, Seong Hoon Shin, et al.
Cancer Research and Treatment|July 2, 2026
Clinico-Pathologic Features of Adult Erdheim-Chester Disease in South Korea: A Multicenter Retrospective Study (KCSG LY22-15)Ji Yun Lee, Heounjeong Go, Myung-Won Lee, et al.
Journal of Audiology & Otology|April 19, 2017
Analysis of Effect of Eggshell Membrane Patching for Moderate-to-Large Traumatic Tympanic Membrane PerforationJong Yoon Jung, Hee-Chul Yun, Tae-Min Kim, et al.
Cancer Medicine|October 5, 2020
Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high-risk human papillomavirus cervical carcinomasJing Jing Liu, Jung Yoon Ho, Jung Eum Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristicsDohee Kwon, Jaemoon Koh, Sehui Kim, et al.
Targeted Oncology|June 8, 2017
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced CancerMichael Michael, Yung-Jue Bang, Young Suk Park, et al.
ESMO Open|August 11, 2018
Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicityShin Hye Yoo, Bhumsuk Keam, Miso Kim, et al.
Investigational New Drugs|September 17, 2013
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamideChanghoon Yoo, Jeeyun Lee, Sun Young Rha, et al.
Pageof 59